At the news
? NEUTRALIMPACT 3/10 8-K filed Apr 2, 2026 at 08:15 ET
Harmony Biosciences appointed Peter Anastasiou as Chief Operating Officer and board member Troy Ignelzi, while two directors, including Anastasiou and Antonio Gracias, stepped down. The company disclosed Anastasiou's employment agreement with a $600,000 base salary and $3.7 million equity grant.
- Peter Anastasiou appointed as Senior Executive Vice President and Chief Operating Officer effective April 2, 2026
- Anastasiou resigned from the board of directors upon becoming COO
- Troy Ignelzi appointed to the board to fill Anastasiou's vacancy
- Antonio Gracias will not stand for re-election at the upcoming annual meeting
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access